HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Monday, 27 June 2011

New NICE topic for HEDS

In the recent round of topic allocations HEDS was given one NICE single technology appraisal (STA).  It is ridaforolimus (brand name unknown!) for the first-line maintenance treatment of metastatic soft tissue or bone sarcoma. The draft scope is available here.

For further information contact Eva Kaltenthaler or Matt Stevenson.